Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Medical Genetics

Understanding Lysinuric Protein Intolerance: A Guide for Families

At a Glance

Lysinuric protein intolerance (LPI) is a rare genetic disorder caused by SLC7A7 gene mutations that prevents the body from processing certain amino acids. This leads to toxic ammonia buildup. LPI is typically managed with a strict low-protein diet and citrulline supplements.

Lysinuric protein intolerance (LPI) is an extremely rare genetic condition that affects how the body handles certain amino acids (the building blocks of protein). It is essential to know from the start: this is not your fault [1]. LPI is an autosomal recessive disorder, meaning a child must inherit one copy of the mutated gene from each parent to have the condition [2][1]. The parents are typically healthy “carriers” who had no way of knowing they carried the gene until their child was diagnosed.

The diagnosis often comes after a long “diagnostic odyssey,” and it is normal to feel a range of emotions, from deep grief and overwhelm to a sense of relief that your child’s symptoms finally have a name [3][4].

Understanding LPI

In people with LPI, the body has trouble transporting three specific amino acids—lysine, arginine, and ornithine—out of the intestines and kidneys [2][5]. Because these amino acids are “trapped” or lost in the urine, the body cannot use them properly. This leads to a breakdown in the urea cycle, the process our bodies use to remove ammonia (a toxic waste product) [6][7].

LPI is caused by mutations in the SLC7A7 gene [1][8]. While it is found worldwide, it is most common in certain regions due to “founder effects” (where a specific mutation is passed down through generations in a specific population):

  • Finland: Approximately 1 in 50,000 people [2].
  • Northern Japan: Approximately 1 in 60,000 people [2].
  • Global: In most other parts of the world, it is significantly rarer [9].

Three Stabilizing Facts

When facing a new diagnosis, it helps to ground yourself in what is known. Here are three core facts about LPI:

  1. The Cause is Genetic, Not Environmental: LPI is caused by a specific change in the SLC7A7 gene [1]. Nothing you did during pregnancy or early childhood caused this condition. Because it is an autosomal recessive condition, it is highly recommended to discuss genetic testing for any siblings of the diagnosed child, even if they appear healthy [1].
  2. Management is Possible: While LPI is a lifelong journey, there are established ways to manage it. Most patients follow a low-protein diet and take a supplement called citrulline to help the body bypass the transport “blockage” and safely remove ammonia [10][11].
  3. Early Intervention Matters: Research shows that an early diagnosis and starting treatment quickly can significantly improve a child’s growth and help prevent long-term complications [12][13].

What to Expect

LPI is a multisystem disorder, meaning it can affect different parts of the body over time. Symptoms often start after a baby is weaned from breast milk or starts eating high-protein solid foods [14][15]. Common early signs include:

  • Failure to thrive: Difficulty gaining weight or growing at the expected rate [16].
  • Protein aversion: A natural, strong dislike of meat and other high-protein foods [14].
  • Enlarged organs: An enlarged liver or spleen (hepatosplenomegaly) [15].

Long-Term Trajectory

While the disease varies from person to person, doctors focus on monitoring four main areas to keep patients healthy:

  • Kidney Health: Regular urine tests help catch early signs of kidney stress [17][18].
  • Lung Health: A rare but serious complication called pulmonary alveolar proteinosis (PAP) can occur, so regular lung check-ups are standard [19][20].
  • Bone Health: Many LPI patients are at risk for low bone density (osteoporosis), which may require vitamin D or other supports [20][18].
  • Immune System: LPI can sometimes cause the immune system to overreact, so doctors watch for signs of inflammation or autoimmune issues [21][8].

Validating Your Experience

It is vital to acknowledge the caregiver burden that comes with a rare disease [22]. Managing a strict diet, specialized medications, and frequent doctor visits is a major life change. Finding “meaning-making” strategies—such as connecting with other rare disease families or focusing on your child’s unique strengths—can help you cope with the stress [23][24]. You are not just a caregiver; you are your child’s strongest advocate.

Common questions in this guide

What causes Lysinuric Protein Intolerance (LPI)?
LPI is caused by a genetic mutation in the SLC7A7 gene. It is an autosomal recessive disorder, meaning a child must inherit one copy of the mutated gene from each parent to develop the condition.
What are the early signs of LPI in babies and toddlers?
Symptoms often appear after a baby is weaned or starts eating high-protein solid foods. Common early signs include difficulty gaining weight, a strong natural dislike of high-protein foods, and an enlarged liver or spleen.
How is LPI typically treated?
Management of LPI usually involves a strict low-protein diet to prevent toxic ammonia buildup. Patients also take a citrulline supplement to help the body safely process and remove ammonia.
What long-term complications can occur with LPI?
Because LPI is a multisystem disorder, it can affect various parts of the body over time. Doctors will regularly monitor patients for potential kidney stress, bone density issues, immune system changes, and a rare lung condition called pulmonary alveolar proteinosis.
Should my other children be tested for LPI?
Because LPI is an autosomal recessive condition, doctors highly recommend discussing genetic testing for any siblings of a diagnosed child, even if they appear completely healthy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my child's specific genetic mutation in the SLC7A7 gene, and what does that mean for their daily care?
  2. 2.How will you monitor for complications like lung or kidney issues, and what signs should I watch for at home?
  3. 3.Can you recommend a metabolic dietitian who has experience specifically with LPI?
  4. 4.What are the goals for my child's blood ammonia and amino acid levels, and how often will we test them?
  5. 5.Are there specific warning signs of an 'acute crisis' that mean I should take my child to the emergency room immediately?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Hyperammonemia in a Child Presenting with Growth Delay, Short Stature, and Diarrhea.

    Almontashiri NAM, Demirbas D, Berry GT, Peake RWA

    Clinical chemistry 2018; (64(8)):1260-1262 doi:10.1373/clinchem.2018.291146.

    PMID: 30054302
  2. 2

    Lysinuric protein intolerance in a family of Mexican ancestry with a novel SLC7A7 gene deletion. Case report and review of the literature.

    Carpentieri D, Barnhart MF, Aleck K, et al.

    Molecular genetics and metabolism reports 2015; (2()):47-50 doi:10.1016/j.ymgmr.2014.12.005.

    PMID: 28649527
  3. 3

    Survey of patient satisfaction with genetic counseling services in Korea.

    Choi IH, Kim YK, Yang SY, et al.

    Journal of genetic counseling 2025; (34(1)):e1922 doi:10.1002/jgc4.1922.

    PMID: 38769825
  4. 4

    Assessing and attending to psychosocial concerns in genetic counseling: Proposing the BATHE method.

    Moscarello T, Higgs E, Pollard E, et al.

    Journal of genetic counseling 2025; (34(3)):e1998 doi:10.1002/jgc4.1998.

    PMID: 39535335
  5. 5

    y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.

    Rotoli BM, Barilli A, Visigalli R, et al.

    Journal of cellular and molecular medicine 2020; (24(1)):921-929 doi:10.1111/jcmm.14801.

    PMID: 31705628
  6. 6

    Dual pathogenic mechanisms in lysinuric protein intolerance: Interplay between hyperammonemia and cellular metabolic dysregulation in astrocyte injury.

    Kakisaka K, Sato T, Wada Y, et al.

    Molecular genetics and metabolism 2025; (145(2)):109134 doi:10.1016/j.ymgme.2025.109134.

    PMID: 40349487
  7. 7

    Lysinuric Protein Intolerance Presenting with Recurrent Hyperammonemic Encephalopathy.

    Bijarnia-Mahay S, Jain V, Bansal RK, et al.

    Indian pediatrics 2016; (53(8)):732-4 doi:10.1007/s13312-016-0920-2.

    PMID: 27567650
  8. 8

    A novel variant in a Chinese boy with lysinuric protein intolerance: A case report and literature review.

    Wang Y, Li H, Huang Z, et al.

    Heliyon 2024; (10(5)):e27044 doi:10.1016/j.heliyon.2024.e27044.

    PMID: 38444501
  9. 9

    Clinical and genetic features of lysinuric protein intolerance in Japan.

    Noguchi A, Nakamura K, Murayama K, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2016; (58(10)):979-983 doi:10.1111/ped.12946.

    PMID: 26865117
  10. 10

    Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI.

    Kärki M, Näntö-Salonen K, Niinikoski H, Tanner LM

    JIMD reports 2016; (25()):47-55 doi:10.1007/8904_2015_465.

    PMID: 26122628
  11. 11

    Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance.

    IJzermans T, van der Meijden W, Hoeks M, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2023; (81(4)):493-496 doi:10.1053/j.ajkd.2022.08.019.

    PMID: 36223829
  12. 12

    Title not available

    Jbebli E, Jbeli Y, Amdouni R, et al.

    La Tunisie medicale 2024; (102(5)):284-288 doi:10.62438/tunismed.v102i5.4792.

    PMID: 38801286
  13. 13

    Heterogeneous colonic content: A prenatal sonographic manifestation of lysinuric protein intolerance.

    Dimitriou C, Saliba S, Peyrassol X, et al.

    Clinical case reports 2020; (8(6)):1010-1014 doi:10.1002/ccr3.2780.

    PMID: 32577254
  14. 14

    [Enteral nutrition support for lysinuric protein intolerance: a case report and literature review].

    Quan J, Liu XF, Hu K, Hou Q

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2023; (25(12)):1270-1275 doi:10.7499/j.issn.1008-8830.2306148.

    PMID: 38112146
  15. 15

    [Clinical features of children with lysinuric protein intolerance and SLC7A7 gene mutation: an analysis of 3 cases].

    Cui D, Hu YH, Tang G, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(4)):375-380.

    PMID: 31014432
  16. 16

    Lysinuric protein intolerance: Pearls to detect this otherwise easily missed diagnosis.

    Alqarajeh F, Omorodion J, Bosfield K, et al.

    Translational science of rare diseases 2020; (5(1-2)):81-86 doi:10.3233/TRD-190035.

    PMID: 33134088
  17. 17

    Renal Involvement in a French Paediatric Cohort of Patients with Lysinuric Protein Intolerance.

    Nicolas C, Bednarek N, Vuiblet V, et al.

    JIMD reports 2016; (29()):11-17 doi:10.1007/8904_2015_509.

    PMID: 26608393
  18. 18

    Lysinuric Protein Intolerance: Not Only a Disorder for Pediatric Nephrologists - Case Report.

    Rigoldi M, Mele C, Breno M, et al.

    Nephron 2025; (149(2)):116-124 doi:10.1159/000541363.

    PMID: 39293417
  19. 19

    Whole lung lavage and GM-CSF use for pulmonary alveolar proteinosis in an infant with lysinuric protein intolerance: a case report.

    Vojcek E, Krikovszky D, Lódi C, et al.

    Italian journal of pediatrics 2024; (50(1)):111 doi:10.1186/s13052-024-01677-y.

    PMID: 38831374
  20. 20

    Lysinuric protein intolerance mimicking N-acetylglutamate synthase deficiency in a nine-year-old boy.

    Al-Qattan S, Malcolmson C, Mercimek-Andrews S

    Molecular genetics and metabolism reports 2021; (27()):100741 doi:10.1016/j.ymgmr.2021.100741.

    PMID: 33763330
  21. 21

    Children with lysinuric protein intolerance: Experience from a lower middle income country.

    Hashmi SB, Ahmed S

    World journal of clinical pediatrics 2022; (11(4)):369-374 doi:10.5409/wjcp.v11.i4.369.

    PMID: 36052112
  22. 22

    Caregiver burden in family caregivers of individuals with cancer in Iran: an analytical cross-sectional study.

    Mirshahi A, Farsi Z, Sajadi SA, et al.

    Journal of health, population, and nutrition 2025; (44(1)):186 doi:10.1186/s41043-025-00929-9.

    PMID: 40468411
  23. 23

    Meaning-Making Among Parents of Children With Severe Neurologic Impairment in the PICU.

    Bogetz JF, Oslin E, O'Donnell M, et al.

    Pediatrics 2024; (153(4)) doi:10.1542/peds.2023-064361.

    PMID: 38529567
  24. 24

    Rise Above: Experiences of Spirituality Among Family Caregivers Caring for Their Dying Family Member in a Hospice Setting in Pakistan.

    Lalani N, Duggleby W, Olson J

    Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association 2019; (21(5)):422-429 doi:10.1097/NJH.0000000000000584.

    PMID: 31318734

This page provides educational information about Lysinuric Protein Intolerance (LPI) for families. Always consult your child's metabolic specialist or pediatrician for personalized medical advice and dietary planning.

Get notified when new evidence is published on Lysinuric protein intolerance.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.